Ruiwu Liu

UC Davis Comprehensive Cancer Center, University of Toronto

Papers

Total Citations

H-Index

About

Ruiwu Liu is a researcher whose work bridges biomedical science and construction automation, demonstrating a unique interdisciplinary trajectory. His early contributions focus on cancer therapeutics, notably his 2004 paper "New approaches in identifying drugs to inactivate oncogene products" (21 citations), which explores innovative strategies for targeting oncogene-driven cancers. This foundational work highlights his interest in drug discovery and molecular biology. More recently, Liu has pivoted to smart construction technologies, co-authoring a 2024 study on "A Computer Vision and Point Cloud-Based Monitoring Approach for Automated Construction Tasks Using Full-Scale Robotized Mobile Cranes" (5 citations). This paper leverages machine learning, modern sensory systems, and robotics to develop an economical monitoring framework for automated construction, reflecting the rapid evolution of smart construction. While his citation counts are modest, his work showcases adaptability and forward-thinking—addressing critical challenges in both health and infrastructure. Liu’s ability to apply computational and robotic methods to real-world problems positions him as a versatile researcher, with potential for growing impact as his recent innovations gain traction.